皮肤性病诊疗学杂志2024，Vol.31Issue(12)：858-864,7.DOI:10.3969/j.issn.1674-8468.2024.12.010
奥马珠单抗在慢性诱导性荨麻疹治疗中的应用进展
Progress in the application of omalizumab in the treatment of chronic inducible urticaria
摘要
Abstract
Chronic inducible urticaria(CIndU)is a chronic urticaria caused by unique trig-gers,manifested by wheals and angioedema as common symptoms.Omalizumab is a recombinant humanized anti-IgE antibody,which is currently listed as the third-line treatment for CIndU in in-ternational guidelines,and there are some precedents for the treatment of CIndU with omalizumab,but the relevant dose,efficacy,adverse reactions and other data are relatively insufficient.The purpose of this article is to review the efficacy and treatment progress of omalizumab in the treat-ment of various types of CIndU,and to provide a rationale for the treatment of patients with CIndU.关键词
奥马珠单抗/慢性诱导性荨麻疹/皮肤划痕征/冷接触性荨麻疹/胆碱能性荨麻疹/延迟压力性荨麻疹Key words
omalizumab/chronic inducible urticaria/dermographia/cold contact urticaria/cholinergic urticaria/delayed-pressure urticaria引用本文复制引用
陈紫嫣,邹荟,林天一,吴伟鸿,陈教全,梁碧华,李润祥,李华平,朱慧兰..奥马珠单抗在慢性诱导性荨麻疹治疗中的应用进展[J].皮肤性病诊疗学杂志,2024,31(12):858-864,7.基金项目
广州市科技计划项目(2024A03J0559) （2024A03J0559）
2024年度市校(院)企联合资助项目(2024A03J0479) （院）
